FR1958M - New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building. - Google Patents

New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.

Info

Publication number
FR1958M
FR1958M FR903960A FR903960A FR1958M FR 1958 M FR1958 M FR 1958M FR 903960 A FR903960 A FR 903960A FR 903960 A FR903960 A FR 903960A FR 1958 M FR1958 M FR 1958M
Authority
FR
France
Prior art keywords
andropause
senescence
disorders
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR903960A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR903960A priority Critical patent/FR1958M/en
Application granted granted Critical
Publication of FR1958M publication Critical patent/FR1958M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR903960A 1962-04-20 1962-07-13 New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building. Active FR1958M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR903960A FR1958M (en) 1962-04-20 1962-07-13 New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR895239A FR1380414A (en) 1962-04-20 1962-04-20 Novel estratriene steroids and method of preparation
FR903960A FR1958M (en) 1962-04-20 1962-07-13 New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.

Publications (1)

Publication Number Publication Date
FR1958M true FR1958M (en) 1963-08-05

Family

ID=8777413

Family Applications (2)

Application Number Title Priority Date Filing Date
FR895239A Expired FR1380414A (en) 1962-04-20 1962-04-20 Novel estratriene steroids and method of preparation
FR903960A Active FR1958M (en) 1962-04-20 1962-07-13 New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR895239A Expired FR1380414A (en) 1962-04-20 1962-04-20 Novel estratriene steroids and method of preparation

Country Status (8)

Country Link
AT (1) AT253694B (en)
BR (1) BR6348531D0 (en)
CH (1) CH414608A (en)
DK (1) DK104232C (en)
ES (1) ES287190A1 (en)
FR (2) FR1380414A (en)
GB (3) GB1035683A (en)
SE (1) SE308310B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183555B1 (en) * 1972-05-10 1975-06-20 Roussel Uclaf
FR2388560A1 (en) * 1977-04-27 1978-11-24 Roussel Uclaf NEW ZOOTECHNICAL COMPOSITIONS CONTAINING ON THE ONE HAND ZERANOL AND ON THE OTHER HAND A STEROID 4,9,11 TRIENIQUE
JP3014784B2 (en) * 1991-02-13 2000-02-28 日本ユクラフ株式会社 Drugs for preventing stress in fish
FR2674436B1 (en) * 1991-03-28 1995-01-20 Roussel Uclaf NEW USE OF 4,9,11-TRIENIC STEROUIDES IN COMPOSITIONS FOR ADMINISTRATION IN TURKEY.
ES2948624T3 (en) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Improved process for the preparation of trenbolone and/or trenbolone acetate
ES3032945T3 (en) * 2020-11-19 2025-07-29 Fis Fabbrica Italiana Sintetici Spa Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
ES3055468T3 (en) * 2020-11-19 2026-02-12 Fis Fabbrica Italiana Sintetici Spa Process for the preparation of trenbolone acetate having a definite particle size distribution

Also Published As

Publication number Publication date
AT253694B (en) 1967-04-25
GB1035684A (en) 1966-07-13
CH414608A (en) 1966-06-15
BR6348531D0 (en) 1973-07-03
ES287190A1 (en) 1963-06-01
SE308310B (en) 1969-02-10
DK104232C (en) 1966-04-25
GB1035685A (en) 1966-07-13
FR1380414A (en) 1964-12-04
GB1035683A (en) 1966-07-13

Similar Documents

Publication Publication Date Title
FR2713M (en) New drug in particular for the treatment of manifestations of hypoandrogenism, disorders of protein anabolism as well as for the treatment of hyperfolliculinia.
FR1958M (en) New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1398M (en) New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR314M (en) New drug in particular for the treatment of disorders of protein anabolism and cell building.
FR15M (en) New drug in particular for the treatment of disorders of protein anabolism and cell building.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR256F (en) New drug, in particular for the treatment of disorders of protein anabolism, manifestations of hypoandrogenism and hyperfolliculin.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR2014M (en) Medicament for the treatment of eczema and other skin diseases, in particular conditions causing baldness.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR3009M (en) New drug in particular for the treatment of protein anabolism and disorders due to hyperfolliculinia.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.